Characteristics and outcomes of antiretroviral-treated HIV-HBV co-infected patients in Canada
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2334
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Characteristics and outcomes of antiretroviral-treated HIV-HBV co-infected patients in Canada ; volume:19 ; number:1 ; day:21 ; month:11 ; year:2019 ; pages:1-10 ; date:12.2019
BMC infectious diseases ; 19, Heft 1 (21.11.2019), 1-10, 12.2019
- Creator
-
Rana, Urvi
Driedger, Matt
Sereda, Paul
Pan, Shenyi
Ding, Erin
Wong, Alex
Walmsley, Sharon
Klein, Marina
Kelly, Deborah
Loutfy, Mona
Thomas, Rejean
Sanche, Stephen
Kroch, Abigail
Machouf, Nima
Roy-Gagnon, Marie-Helene
Hogg, Robert
Cooper, Curtis L.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12879-019-4617-8
- URN
-
urn:nbn:de:101:1-2020032300481145569703
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:56 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Rana, Urvi
- Driedger, Matt
- Sereda, Paul
- Pan, Shenyi
- Ding, Erin
- Wong, Alex
- Walmsley, Sharon
- Klein, Marina
- Kelly, Deborah
- Loutfy, Mona
- Thomas, Rejean
- Sanche, Stephen
- Kroch, Abigail
- Machouf, Nima
- Roy-Gagnon, Marie-Helene
- Hogg, Robert
- Cooper, Curtis L.
- SpringerLink (Online service)
Other Objects (12)
Investigating factors associated to HBV/HIV co-infected patients in antiretroviral treatment clinic, in Northeast Ethiopia
HIV lamivudine resistance mutations in HBV co-infected Romanian patients
Management of HIV-2 resistance to antiretroviral therapy in a HIV-1/HIV-2/HBV co-infected patient
Liver damage in HIV+HBV co-infected patients determined by transient elastography
Transmission of Hepatitis B virus (HBV) minor variants in children born to HBV/HIV co-infected mothers
Molecular analysis of hepatitis B virus (HBV) in an HIV co-infected patient with reactivation of occult HBV infection following discontinuation of lamivudine-including antiretroviral therapy
Hepatitis B virus variants in an HIV-HBV co-infected patient at different periods of antiretroviral treatment with and without lamivudine
Emergence of HBV resistance to lamivudine (3TC) in HIV/HBV co-infected patients in The Gambia, West Africa
Hepatitis B virus (HBV) genotype distribution and lamivudine-resistant mutations in HIV/HBV co-infected patients attending a Parisian hospital
Atazanavir is safe and efficacious in HBV and HCV co-infected patients: results of AI424138 (CASTLE)
HBV genotypes and response to tenofovir disoproxil fumarate in HIV/HBV-coinfected persons
High prevalence of genotype G in HIV co-infected patients compared with HBV monoinfected patients in México
Investigating factors associated to HBV/HIV co-infected patients in antiretroviral treatment clinic, in Northeast Ethiopia
HIV lamivudine resistance mutations in HBV co-infected Romanian patients
Management of HIV-2 resistance to antiretroviral therapy in a HIV-1/HIV-2/HBV co-infected patient
Liver damage in HIV+HBV co-infected patients determined by transient elastography
Transmission of Hepatitis B virus (HBV) minor variants in children born to HBV/HIV co-infected mothers
Molecular analysis of hepatitis B virus (HBV) in an HIV co-infected patient with reactivation of occult HBV infection following discontinuation of lamivudine-including antiretroviral therapy
Hepatitis B virus variants in an HIV-HBV co-infected patient at different periods of antiretroviral treatment with and without lamivudine
Emergence of HBV resistance to lamivudine (3TC) in HIV/HBV co-infected patients in The Gambia, West Africa
Hepatitis B virus (HBV) genotype distribution and lamivudine-resistant mutations in HIV/HBV co-infected patients attending a Parisian hospital
Atazanavir is safe and efficacious in HBV and HCV co-infected patients: results of AI424138 (CASTLE)
HBV genotypes and response to tenofovir disoproxil fumarate in HIV/HBV-coinfected persons
High prevalence of genotype G in HIV co-infected patients compared with HBV monoinfected patients in México
Investigating factors associated to HBV/HIV co-infected patients in antiretroviral treatment clinic, in Northeast Ethiopia
HIV lamivudine resistance mutations in HBV co-infected Romanian patients
Management of HIV-2 resistance to antiretroviral therapy in a HIV-1/HIV-2/HBV co-infected patient
Liver damage in HIV+HBV co-infected patients determined by transient elastography
Transmission of Hepatitis B virus (HBV) minor variants in children born to HBV/HIV co-infected mothers
Molecular analysis of hepatitis B virus (HBV) in an HIV co-infected patient with reactivation of occult HBV infection following discontinuation of lamivudine-including antiretroviral therapy
Hepatitis B virus variants in an HIV-HBV co-infected patient at different periods of antiretroviral treatment with and without lamivudine
Emergence of HBV resistance to lamivudine (3TC) in HIV/HBV co-infected patients in The Gambia, West Africa
Hepatitis B virus (HBV) genotype distribution and lamivudine-resistant mutations in HIV/HBV co-infected patients attending a Parisian hospital
Atazanavir is safe and efficacious in HBV and HCV co-infected patients: results of AI424138 (CASTLE)
HBV genotypes and response to tenofovir disoproxil fumarate in HIV/HBV-coinfected persons